These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 10574906)
41. Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial? Bristow MR; Feldman AM; Adams KF; Goldstein S J Card Fail; 2003 Dec; 9(6):444-53. PubMed ID: 14966783 [TBL] [Abstract][Full Text] [Related]
42. Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol. Gardner RS; McGowan J; McDonagh TA Eur J Heart Fail; 2002 Jun; 4(3):377-9. PubMed ID: 12034165 [TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure. Talbert RL Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861 [TBL] [Abstract][Full Text] [Related]
44. Current research on carvedilol in heart failure. Bobadilla RV Crit Care Nurse; 2002 Aug; 22(4):14, 16. PubMed ID: 12166050 [No Abstract] [Full Text] [Related]
45. Carvedilol versus other beta-blockers in heart failure. Doggrell SA Expert Opin Investig Drugs; 2001 May; 10(5):971-80. PubMed ID: 11322870 [TBL] [Abstract][Full Text] [Related]
46. Beta blockade in patients with congestive heart failure. Why, who, and how. Frantz RP Postgrad Med; 2000 Sep; 108(3):103-6, 109-10, 116-8. PubMed ID: 11004938 [TBL] [Abstract][Full Text] [Related]
47. Carvedilol in the failing heart. Lombardi WL; Gilbert EM Clin Cardiol; 2001 Dec; 24(12):757-66. PubMed ID: 11768738 [TBL] [Abstract][Full Text] [Related]
48. Unique effects of carvedilol on noradrenaline release in the human heart. Richardt G; Richardt D; Adler S; Kraatz E; Nötzold A; Kurz T Eur J Heart Fail; 2002 Mar; 4(2):147-9. PubMed ID: 11959042 [No Abstract] [Full Text] [Related]
50. Influence of beta-blockers on mortality in chronic heart failure. Hart SM Ann Pharmacother; 2000 Dec; 34(12):1440-51. PubMed ID: 11144703 [TBL] [Abstract][Full Text] [Related]
51. Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease. Su VY; Chang YS; Hu YW; Hung MH; Ou SM; Lee FY; Chou KT; Yang KY; Perng DW; Chen TJ; Liu CJ Medicine (Baltimore); 2016 Feb; 95(5):e2427. PubMed ID: 26844454 [TBL] [Abstract][Full Text] [Related]
52. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?]. vom Dahl J; Schotten U; Sasse A Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047 [No Abstract] [Full Text] [Related]
54. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world? Wollert KC; Drexler H Circulation; 2002 Oct; 106(17):2164-6. PubMed ID: 12390940 [No Abstract] [Full Text] [Related]
55. [Use of beta-blockers in heart failure]. Inoko M; Nohara R Nihon Rinsho; 2003 May; 61(5):816-20. PubMed ID: 12755008 [TBL] [Abstract][Full Text] [Related]
56. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Doughty RN; Rodgers A; Sharpe N; MacMahon S Eur Heart J; 1997 Apr; 18(4):560-5. PubMed ID: 9129883 [TBL] [Abstract][Full Text] [Related]
57. QT dispersion after beta-blocker therapy (carvedilol or metoprolol) in children with heart failure. Etheridge SP; Shaddy RE Am J Cardiol; 2003 Jun; 91(12):1497-500, A8. PubMed ID: 12804745 [No Abstract] [Full Text] [Related]
58. [Beta-adrenolytics in heart failure--are they all really equal?]. Filipiak KJ; Opolski G Przegl Lek; 2005; 62 Suppl 2():39-42. PubMed ID: 16623117 [TBL] [Abstract][Full Text] [Related]
59. Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients. Lin TY; Chen CY; Huang YB Int J Cardiol; 2017 Mar; 230():378-383. PubMed ID: 28041715 [TBL] [Abstract][Full Text] [Related]